Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-05-11
1999-10-05
Mach, D M
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546141, 546143, 546146, 546147, A61K 3147, A61K 31475, C07D21722, C07D21700
Patent
active
059624710
ABSTRACT:
Compounds of the formula I ##STR1## are suitable for the preparation of pharmaceuticals for the prophylaxis and therapy of disorders involving increased activity of matrix-degrading metalloproteinases.
REFERENCES:
patent: 4613606 (1986-09-01), Clark et al.
patent: 4681889 (1987-07-01), Clark et al.
patent: 5393760 (1995-02-01), Ackermann et al.
patent: 5455258 (1995-10-01), MacPherson
patent: 5506242 (1996-04-01), MacPherson
patent: 5506258 (1996-04-01), Christophe et al.
patent: 5532232 (1996-07-01), Ackermann et al.
patent: 5552419 (1996-09-01), MacPherson
patent: 5583133 (1996-12-01), Ackermann et al.
patent: 5595999 (1997-01-01), Ackermann et al.
patent: 5674890 (1997-10-01), Christophe et al.
patent: 5714497 (1998-02-01), Christophe et al.
chemical Abstracts 113:6182, abstract of JP 02009863, Okada, 1990.
Chemical Abstracts 128:102014, abstract of WO 9800403, Dominianni, 1998.
chemical Abstracts 127:65701, abstract of WO 9718194, Thorwart, 1997.
Fosang et al., "Aggrecan is Degraded by Matrix Metalloproteinases in Human Arthritis," J. Clin. Invest., 98(10):2292-2299 (1996).
CA 112:76983, Tripathi, 1989.
Hoechst Aktiengesellschaft
Mach D M
LandOfFree
Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171792